Enrolling by invitationNCT05880576
The Arch Watch Study: An Integrated Evaluation of Hemodynamics in Infants With Suspected Coarctation of the Aorta
Studying OBSOLETE: Autosomal dominant coarctation of aorta
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- John Kheir, MDBoston Children's Hospital
- Intervention
- Monitoring using resonance Raman spectroscopy, pulse oximetry, blood pressure, and near-infrared spectroscopy(device)
- Enrollment
- 60 enrolled
- Eligibility
- All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- Boston Children's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05880576 on ClinicalTrials.govOther trials for OBSOLETE: Autosomal dominant coarctation of aorta
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07134621Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced HypertensionUniversity Medical Centre Ljubljana
- RECRUITINGNANCT07316855Evaluating the Feasibility of Bioresorbable Iron-Based Covered Stent: A Clinical TrialShubo Song
- RECRUITINGNCT06759103Electronic Archive of Patients With Diagnosis and Suspected Prenatal Diagnosis of Aortic CoarctationIRCCS Azienda Ospedaliero-Universitaria di Bologna
- ACTIVE NOT RECRUITINGNANCT05086016Growth Trial: Study of the Renata Minima StentRenata Medical
- ACTIVE NOT RECRUITINGNCT05362721PV Loop & Coarctation StudyUniversity of Minnesota
See all trials for OBSOLETE: Autosomal dominant coarctation of aorta →